Skip to main content
Top
Published in: European Journal of Epidemiology 8/2013

01-08-2013 | METABOLIC SYNDROME

Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population

Authors: Xiayun Dai, Jing Yuan, Ping Yao, Binyao Yang, Lixuan Gui, Xiaomin Zhang, Huan Guo, Youjie Wang, Weihong Chen, Sheng Wei, Xiaoping Miao, Xiulou Li, Xinwen Min, Handong Yang, Weimin Fang, Yuan Liang, Frank B. Hu, Tangchun Wu, Meian He

Published in: European Journal of Epidemiology | Issue 8/2013

Login to get access

Abstract

Our aim was to study whether there is causal association between serum uric acid and metabolic syndrome (MetS). A cross-sectional study was performed, including a total of 27,009 subjects (23,345 subjects having uric acid data) from the Dongfeng-Tongji Cohort study. The MetS was defined by the International Diabetes Foundation criteria of 2005. Association analysis was performed by logistic regression. A genetic risk score was calculated by adding the uric acid increasing alleles in two SNPs (rs11722228 in SLC2A9 and rs2231142 in ABCG2) which were identified from our genome-wide association study on uric acid levels. The causal association was examined by mendelian randomization analysis. Among a middle- and old-age Chinese population, serum uric acid concentrations were strongly associated with the risk of MetS and its several components (P < 0.0001). The effects were stronger in women than in men. Despite the lack of statistical significance, both SNPs exhibited a trend with increased MetS risk (rs11722228, OR = 1.06, 95 % CI 0.99–1.14; rs2231142, OR = 1.02, 95 % CI 0.95–1.10), consistent with their increasing uric acid effects. Each additional uric acid increasing allele in the genetic risk score was associated with 3 % increased MetS risk (OR = 1.03, 95 % CI 0.98–1.09; P = 0.23). Further adjustment for serum uric acid attenuated the trend of individual SNP and genetic risk score with increased MetS risk (all OR < 1.0). These findings suggested that serum uric acid was associated with MetS risk in a middle- and old-age Chinese population. Whether this association was causal remained to be investigated in the future studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care. 2004;27(10):2444–9.PubMedCrossRef Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care. 2004;27(10):2444–9.PubMedCrossRef
2.
go back to reference Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365(9468):1398–405.PubMedCrossRef Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365(9468):1398–405.PubMedCrossRef
3.
go back to reference Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9.PubMedCrossRef Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683–9.PubMedCrossRef
4.
go back to reference Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41(6):715–22.PubMedCrossRef Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41(6):715–22.PubMedCrossRef
5.
go back to reference Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140(3):167–74.PubMedCrossRef Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140(3):167–74.PubMedCrossRef
6.
go back to reference Trevisan M, Liu J, Bahsas FB, et al. Syndrome X and mortality: a population-based study. Risk factor and life expectancy research group. Am J Epidemiol. 1998;148(10):958–66.PubMedCrossRef Trevisan M, Liu J, Bahsas FB, et al. Syndrome X and mortality: a population-based study. Risk factor and life expectancy research group. Am J Epidemiol. 1998;148(10):958–66.PubMedCrossRef
7.
go back to reference Ford ES, Li C, Cook S, et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007;115(19):2526–32.PubMedCrossRef Ford ES, Li C, Cook S, et al. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007;115(19):2526–32.PubMedCrossRef
8.
go back to reference Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006;47(1):51–9.PubMedCrossRef Siu YP, Leung KT, Tong MK, et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006;47(1):51–9.PubMedCrossRef
9.
go back to reference Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001;87(12):1411–4.PubMedCrossRef Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001;87(12):1411–4.PubMedCrossRef
10.
go back to reference Chiou WK, Wang MH, Huang DH, et al. The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J Epidemiol. 2010;20(3):219–24.PubMedCrossRef Chiou WK, Wang MH, Huang DH, et al. The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J Epidemiol. 2010;20(3):219–24.PubMedCrossRef
11.
go back to reference Nan H, Qiao Q, Soderberg S, et al. Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. Metab Syndr Relat Disord. 2008;6(1):47–57.PubMedCrossRef Nan H, Qiao Q, Soderberg S, et al. Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. Metab Syndr Relat Disord. 2008;6(1):47–57.PubMedCrossRef
12.
go back to reference Ryu S, Song J, Choi BY, et al. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol. 2007;17(4):245–52.PubMedCrossRef Ryu S, Song J, Choi BY, et al. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol. 2007;17(4):245–52.PubMedCrossRef
13.
go back to reference Sui X, Church TS, Meriwether RA, et al. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008;57(6):845–52.PubMedCrossRef Sui X, Church TS, Meriwether RA, et al. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008;57(6):845–52.PubMedCrossRef
14.
go back to reference Yang T, Chu CH, Bai CH, et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis. 2012;220(2):525–31.PubMedCrossRef Yang T, Chu CH, Bai CH, et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis. 2012;220(2):525–31.PubMedCrossRef
15.
go back to reference Zhang Q, Zhang C, Song X, et al. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Han Chinese urban population. BMC Public Health. 2012;12(1):419.PubMedCrossRef Zhang Q, Zhang C, Song X, et al. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Han Chinese urban population. BMC Public Health. 2012;12(1):419.PubMedCrossRef
16.
go back to reference Chen LK, Lin MH, Lai HY, et al. Uric acid: a surrogate of insulin resistance in older women. Maturitas. 2008;59(1):55–61.PubMedCrossRef Chen LK, Lin MH, Lai HY, et al. Uric acid: a surrogate of insulin resistance in older women. Maturitas. 2008;59(1):55–61.PubMedCrossRef
17.
go back to reference Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287–93.PubMedCrossRef Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287–93.PubMedCrossRef
18.
go back to reference Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med. 2008;47(13):1175–80.PubMedCrossRef Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med. 2008;47(13):1175–80.PubMedCrossRef
19.
go back to reference Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290(3):F625–31.PubMedCrossRef Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290(3):F625–31.PubMedCrossRef
20.
go back to reference Santos RD. Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander? Endocrine. 2012;41(3):350–2.PubMedCrossRef Santos RD. Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander? Endocrine. 2012;41(3):350–2.PubMedCrossRef
21.
22.
go back to reference Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet. 2010;42(3):210–5.PubMedCrossRef Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet. 2010;42(3):210–5.PubMedCrossRef
23.
go back to reference Wallace C, Newhouse SJ, Braund P, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008;82(1):139–49.PubMedCrossRef Wallace C, Newhouse SJ, Braund P, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008;82(1):139–49.PubMedCrossRef
24.
go back to reference Dehghan A, Kottgen A, Yang Q, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654):1953–61.PubMedCrossRef Dehghan A, Kottgen A, Yang Q, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654):1953–61.PubMedCrossRef
25.
go back to reference Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.PubMedCrossRef Alberti KG, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.PubMedCrossRef
26.
go back to reference Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–52.PubMedCrossRef
28.
go back to reference Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.PubMedCrossRef Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133–63.PubMedCrossRef
29.
go back to reference Li S, Zhao JH, Luan J, et al. Genetic predisposition to obesity leads to increased risk of type 2 diabetes. Diabetologia. 2011;54(4):776–82.PubMedCrossRef Li S, Zhao JH, Luan J, et al. Genetic predisposition to obesity leads to increased risk of type 2 diabetes. Diabetologia. 2011;54(4):776–82.PubMedCrossRef
30.
go back to reference Freathy RM, Timpson NJ, Lawlor DA, et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 2008;57(5):1419–26.PubMedCrossRef Freathy RM, Timpson NJ, Lawlor DA, et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 2008;57(5):1419–26.PubMedCrossRef
31.
go back to reference Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008;40(4):437–42.PubMedCrossRef Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008;40(4):437–42.PubMedCrossRef
32.
go back to reference Yamagishi K, Tanigawa T, Kitamura A, et al. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people. Rheumatology (Oxford). 2010;49(8):1461–5.CrossRef Yamagishi K, Tanigawa T, Kitamura A, et al. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people. Rheumatology (Oxford). 2010;49(8):1461–5.CrossRef
33.
go back to reference Woodward OM, Kottgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA. 2009;106(25):10338–42.PubMedCrossRef Woodward OM, Kottgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA. 2009;106(25):10338–42.PubMedCrossRef
34.
go back to reference Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30–42.PubMedCrossRef Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33(1):30–42.PubMedCrossRef
35.
go back to reference Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16(4):309–30.PubMedCrossRef Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16(4):309–30.PubMedCrossRef
Metadata
Title
Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population
Authors
Xiayun Dai
Jing Yuan
Ping Yao
Binyao Yang
Lixuan Gui
Xiaomin Zhang
Huan Guo
Youjie Wang
Weihong Chen
Sheng Wei
Xiaoping Miao
Xiulou Li
Xinwen Min
Handong Yang
Weimin Fang
Yuan Liang
Frank B. Hu
Tangchun Wu
Meian He
Publication date
01-08-2013
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 8/2013
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-013-9829-4

Other articles of this Issue 8/2013

European Journal of Epidemiology 8/2013 Go to the issue